Does AMRUBICIN Cause Myelodysplastic syndrome? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Myelodysplastic syndrome have been filed in association with AMRUBICIN. This represents 3.8% of all adverse event reports for AMRUBICIN.
6
Reports of Myelodysplastic syndrome with AMRUBICIN
3.8%
of all AMRUBICIN reports
0
Deaths
1
Hospitalizations
How Dangerous Is Myelodysplastic syndrome From AMRUBICIN?
Of the 6 reports, 1 (16.7%) required hospitalization, and 3 (50.0%) were considered life-threatening.
Is Myelodysplastic syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMRUBICIN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does AMRUBICIN Cause?
Disease recurrence (30)
Neutropenia (22)
Drug ineffective (21)
Interstitial lung disease (17)
Febrile neutropenia (16)
Leukopenia (15)
Anaemia (14)
Acute myeloid leukaemia (13)
Disease progression (12)
Thrombocytopenia (12)
What Other Drugs Cause Myelodysplastic syndrome?
CYCLOPHOSPHAMIDE (1,545)
LENALIDOMIDE (1,285)
DOXORUBICIN (1,236)
RITUXIMAB (1,054)
VINCRISTINE (966)
ETOPOSIDE (936)
DEXAMETHASONE (759)
METHOTREXATE (728)
CYTARABINE (715)
CARBOPLATIN (698)
Which AMRUBICIN Alternatives Have Lower Myelodysplastic syndrome Risk?
AMRUBICIN vs AMSACRINE
AMRUBICIN vs ANAGRELIDE
AMRUBICIN vs ANAKINRA
AMRUBICIN vs ANAMORELIN
AMRUBICIN vs ANASTROZOLE